FDA warns Boston Sci over stent-graft system problems

FDA warns Boston Sci over stent-graft system problems: "Boston Scientific Corp. received a warning letter from U.S. regulators concerning safety violations, including failing to promptly report the deaths of five patients enrolled in clinical trials of a device used to treat ruptured blood vessels in the abdomen."